Synbiotic Compound to Reduce Symptoms of Schizophrenia
NCT04226898
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
BIOLOGICAL:
Synbiotic Supplement
BIOLOGICAL:
Inert Compound
Sponsor
Sheppard Pratt Health System